This is not the most recent version of the article. View current version (19 MAY 2015)

Intervention Protocol

You have free access to this content

Rapid COJEC versus standard induction therapies for high-risk neuroblastoma

  1. Frank Peinemann1,*,
  2. Doreen A Tushabe2,
  3. Frank Berthold3

Editorial Group: Cochrane Childhood Cancer Group

Published Online: 8 OCT 2013

DOI: 10.1002/14651858.CD010774


How to Cite

Peinemann F, Tushabe DA, Berthold F. Rapid COJEC versus standard induction therapies for high-risk neuroblastoma (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010774. DOI: 10.1002/14651858.CD010774.

Author Information

  1. 1

    Children's Hospital, University of Cologne, Cologne, NW, Germany

  2. 2

    University of Birmingham, Public Health, Epidemiology & Biostatistics, Birmingham, UK

  3. 3

    Children's Hospital, University of Cologne, Pediatric Oncology and Hematology, Cologne, Germany

*Frank Peinemann, Children's Hospital, University of Cologne, Kerpener Str. 62, Cologne, NW, 50937, Germany. pubmedprjournal@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 8 OCT 2013

SEARCH

This is not the most recent version of the article. View current version (19 MAY 2015)

References

Additional references

Berthold 2005
  • Berthold F, Boos J, Burdach S, Erttmann R, Henze G, Hermann J, et al. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial. Lancet Oncology 2005;6(9):649-58.
Brisse 2011
  • Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 2011;261(1):243-57.
Brodeur 1993
  • Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. Journal of Clinical Oncology 1993;11(8):1466-77.
ClinicalTrials.gov 2013
  • NIH National Institutes of Health. ClinicalTrials.gov. http://clinicaltrials.gov/.
Cohn 2009
  • Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. Journal of Clinical Oncology 2009;27(2):289-97.
Cole 2012
DerSimonian 1986
Esiashvili 2007
GARD 2013
  • Genetic and Rare Diseases Information Center (GARD), The Office of Rare Diseases Research (ORDR). Neuroblastoma. http://rarediseases.info.nih.gov/GARD/Condition/7185/Neuroblastoma.aspx (accessed 08 July 2013).
Goodman 2012
  • Goodman MT, Gurney JG, Smith MA, Olshan AF. SEER Pediatric Monograph. Sympathetic Nervous System Tumors. http://seer.cancer.gov/publications/childhood/sympathetic.pdf (accessed 08 July 2013).
GPOH 2007
  • Gesellschaft für Pädiatrische Onkologie und Hämatologie. NB2004 High risk trial protocol for the treatment of children with high risk neuroblastoma. http://protiv-raka.org/wp-content/uploads/2011/02/protokol_neuroblastoma.pdf (accessed 25 September 2013); Vol. Version: 3.00 from 01.05.2007.
GRADEpro 2008
  • Information Management System (IMS), The Nordic Cochrane Centre, The Cochrane Collaboration. GRADEpro (GRADE profiler). 3.2 for Window. Copenhagen: Information Management System (IMS), The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
Hero 2008
  • Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG, et al. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. Journal of Clinical Oncology 2008;26(9):1504-10.
Higgins 2003
Higgins 2011a
  • Higgins JPT, Altman DG, Sterne JAC. Table 8.5.a The Cochrane Collaboration's tool for assessing risk of bias. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Higgins 2011b
  • Higgins JPT, Altman DG, Sterne JAC. Table 8.5.d Criteria for judging risk of bias in the 'Risk of bias' assessment tool. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Higgins 2011c
  • Higgins JPT, Deeks JJ, Altman DG. 16.1 Missing data. Chapter 16:  Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
ICSSC 2003
  • International Clinical Studies Support Center (ICSSC). WHO Toxicity Grading Scale for Determining The Severity of Adverse Events. http://www.icssc.org/Documents/Resources/AEManual2003AppendicesFebruary_06_2003%20final.pdf (accessed 25 September 2013.
ICTRP 2013
  • ICTRP International Clinical Trials Registry Platform, WHO World Health Organization. ICTRP Search Platform. http://www.who.int/ictrp/en/ (accessed 25 September 2013).
Kremer 2008
  • Kremer LCM, van Dalen EC, Moher D, Caron HN. Cochrane Childhood Cancer Group. About The Cochrane Collaboration 2008, Issue 3. Art. No.: CHILDCA.
Ladenstein 2010
  • Ladenstein R, Valteau-Couanet D, Brock P, Yaniv I, Castel V, Laureys G, et al. Randomized trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study. Journal of Clinical Oncology 2010;28(21):3516-24.
Lefebvre 2011
  • Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated Marchr 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Matthay 1999
  • Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. New England Journal of Medicine 1999;341(16):1165-73.
Matthay 2009
  • Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, et al. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. Journal of Clinical Oncology 2009;27(7):1007-13.
Moher 2009
NCI CTCAE 2013
  • National Cancer Institute (NCI), Bethesda, MD, USA. Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC). http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm (accessed 25 September 2013).
NCI PDQ 2013
  • National Cancer Institute (NCI) at the National Institutes of Health (NIH), Physician Data Query (PDQ). Neuroblastoma treatment. http://www.cancer.gov/cancertopics/pdq/treatment/neuroblastoma/HealthProfessional (accessed 25 September 2013).
Parmar 1998
Pearson 2008
  • Pearson AD, Pinkerton CR, Lewis IJ, Imeson J, Ellershaw C, Machin D, et al. High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial. Lancet Oncology 2008;9(3):247-56.
Review Manager 2011
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Schünemann 2011
  • Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Sterne 2011
  • Sterne JAC, Egger M, Moher D. Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Thomson Reuters Corp 2013
  • Thomson Reuters. EndNote. X3. New York City: Thomson Reuters, 2013.
Tierney 2007